How much money did MiniMed raise in its IPO?

MiniMed successfully raised $560 million in its U.S. initial public offering.

MiniMed is the diabetes business unit of the medical device maker Medtronic.

When did MiniMed's IPO take place?

The initial public offering for MiniMed took place on March 5.

Home / Business and Economy / MiniMed Secures $560M in U.S. Stock Market Debut

MiniMed Secures $560M in U.S. Stock Market Debut

6 Mar

•

Summary

MiniMed, Medtronic's diabetes unit, successfully completed its IPO.
The initial public offering raised a substantial $560 million.
The company's shares were offered to the U.S. public market.

MiniMed Secures $560M in U.S. Stock Market Debut

MiniMed, the diabetes-focused business unit of medical device manufacturer Medtronic, announced on Thursday that it has successfully raised $560 million through its initial public offering (IPO) in the United States.

This significant capital infusion occurred on March 5, marking a major financial event for the company. The IPO represents MiniMed's debut on the U.S. public market.

Medtronic's diabetes arm is now positioned to leverage this funding. The event was reported from Bengaluru and Mexico City, highlighting its international scope.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.